Amended Statement of Ownership (sc 13g/a)
March 19 2019 - 2:31PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C.
20549
SCHEDULE 13G
Under the Securities
Exchange Act of 1934
(Amendment No. 1)*
SOLENO THERAPEUTICS
INC.
(Name of Issuer)
Common Stock
(Title of Class of
Securities)
834203200
(CUSIP Number)
March 15, 2019
(Date of Event which
Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
x
|
Rule 13d-1(b)
|
¨
|
Rule 13d-1(c)
|
¨
|
Rule 13d-1(d)
|
*The remainder of this cover page shall be filled out for a
reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment
containing information which would alter the disclosures provided in a prior cover page.
The information required on the remainder of this cover page
shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”)
or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
Continued on following
pages
Page 1 of 4 Pages
CUSIP NO. 834203200
|
Page 2 of 4 Pages
|
CUSIP No. 834203200
|
(1) Names of reporting persons
|
Birchview
Capital, LP
|
(2)
Check the appropriate box if a member of a group
|
(a)
|
(see
instructions)
|
(b)
|
(3)
SEC use only
|
|
(4) Citizenship or place of organization
|
DE
|
|
|
Number of shares beneficially owned by
each reporting person with:
|
|
(5)
Sole voting power
|
742,635
|
(6) Shared voting power
|
0
|
(7)
Sole dispositive power
|
742,635
|
(8) Shared dispositive power
|
0
|
|
|
(9) Aggregate amount beneficially owned
by each reporting person
|
742,635
|
(10)
Check if the aggregate amount in Row (9) excludes certain shares (see instructions)
|
|
(11) Percent of class represented by
amount in Row (9)
|
2.3%
|
(12)
Type of reporting person (see instructions)
|
IA
|
Item 1(a).
|
Name of Issuer:
|
|
|
|
SOLENO THERAPEUTICS, INC. (the “Issuer”).
|
|
|
Item 1(b).
|
Address of the Issuer’s Principal Executive Offices:
|
|
|
|
1235 Radio Road, Suite 110, Redwood City, CA 94065.
|
|
|
Item 2(a).
|
Name of Person Filing
|
|
|
|
Birchview Capital, LP (the “Reporting Person”).
|
|
|
Item 2(b).
|
Address of Principal Business Office or, if None, Residence:
|
|
|
|
688 Pine Street, Suite D, Burlington, VT 05401.
|
Item 2(c).
|
Citizenship:
|
|
|
|
The Reporting Person is a Delaware limited partnership.
|
|
|
Item 2(d).
|
Title of Class of Securities:
|
|
|
|
Common Stock (the “Shares”) and
Warrants for Common Stock (the “Warrants”).
|
|
|
Item 2(e).
|
CUSIP Number:
|
|
|
|
834203200
|
CUSIP NO. 834203200
|
Page 3 of 4 Pages
|
Item 3.
|
If this statement is filed
pursuant to Rule 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
|
|
|
|
(a)
¨
Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
¨
Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
¨
Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
¨
Investment
company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
(e)
x
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
(f)
¨
An employee
benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
(g)
¨
A parent
holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
¨
A savings
associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
¨
A church
plan that is excluded from the definition of an investment company under section 3(c)(14) of the
Investment Company
Act of 1940 (15 U.S.C. 80a-3);
(j)
¨
Group,
in accordance with §240.13d-1(b)(1)(ii)(J).
|
|
|
Item 4.
|
Ownership:
|
|
|
Item 4(a).
|
Amount Beneficially Owned:
As of the date hereof, the Reporting Person may be
deemed to be the beneficial owner of 742,635 Shares.
|
|
|
Item 4(b).
|
Percent of Class:
As of the date hereof, the Reporting Person may be
deemed to be the beneficial owner of 2.3% of the total number of Shares outstanding (based on information provided by
the Issuer on the Form 8-K filed March 18, 2019, there were 31,755,169 Shares outstanding as of December 31, 2018).
|
Item 4(c).
|
Number of shares as to which such person has:
|
|
|
|
Birchview Capital, LP
|
|
|
|
(i)
|
Sole power to vote or direct the vote
|
742,635
|
|
(ii)
|
Shared power to vote or to direct the vote
|
0
|
|
(iii)
|
Sole power to dispose or to direct the disposition of
|
742,635
|
|
(iv)
|
Shared power to dispose or to direct the disposition of
|
0
|
CUSIP NO. 834203200
|
Page 4 of 4 Pages
|
Item 5.
|
Ownership of Five Percent or Less of a Class:
|
|
|
|
This statement is being filed
to report the fact that as of the date hereof the Reporting Person has ceased to be the beneficial
owner of more than five percent of the class of securities.
|
|
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person:
|
|
|
|
This Item 6 is not applicable.
|
|
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired
the Security Being Reported on by the Parent Holding Company:
|
|
|
|
This Item 7 is not applicable.
|
|
|
Item 8.
|
Identification and Classification of Members of the Group:
|
|
|
|
This Item 8 is not applicable.
|
|
|
Item 9.
|
Notice of Dissolution of Group:
|
|
|
|
This Item 9 is not applicable.
|
|
|
Item 10.
|
Certification:
|
|
By signing below the Reporting Person certifies that, to the best of
such person’s knowledge and belief, the securities referred to above were not acquired and are not held for the purpose
of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are
not held in connection with or as a participant in any transaction having such purpose or effect.
|
SIGNATURES
After reasonable inquiry and to the best
of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
Date: March 15, 2019
|
Birchview Capital, LP
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Richard
McCormick
|
|
|
|
Richard McCormick
|
|
|
|
Chief Financial Officer
|
|
Soleno Therapeutics (NASDAQ:SLNO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Soleno Therapeutics (NASDAQ:SLNO)
Historical Stock Chart
From Apr 2023 to Apr 2024